Recent studies reveal that common non-antibiotic medications can impair the gut microbiome's ability to resist colonization by harmful pathogens. This disruption may arise through alterations in microbial community dynamics and pathogen interactions, thus influencing infection susceptibility. These findings call for a reevaluation of drug impacts on microbiota and the consideration of microbiome health in therapeutic strategies.